Daily Recap - WEDNESDAY
Join panelists Drs. Janet Pope, Richard Conway, Meral El Ramahi and Jack Cush recap the best presentations presented on day four of the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →What's hot
View all perspectives
What's Hot
EXXELERATE Study: Do High RF Titers Impact Response to TNF Inhibitors?
Dr. Jonathan Kay discusses abstract 2148 with Dr. Josef Smolen at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Bimekizumab in Active AS: 5 Year Study
Dr. Atul Deodhar reporting on abstract 0519 from the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Cannabinoid Receptor in RA Patients
Dr. Arthur Kavanaugh discusses abstract 0025 at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Treatments in SpA
Dr. Rachel Tate and Dr. Catherine Blakewell discuss treatment options patients in spondyloarthritis at the 2023 ACR Convergence meeting in San Diego, CA. Abstracts discussed include 0520, 0530, 0521 and 0529.
Watch video →
PR3+ in Lupus Nephritis
Dr. Jack Cush discusses abstract 2427 presented at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Simulated Trials to Counter ORAL Survelliance
Dr. Jack Cush and Dr. Janet Pope at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Difficult to Treat axSpA
Dr. Peter Nash reports on abstracts 0514 and 0538 from the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Window of Opportunity in PsA
Dr. Peter Nash discusses a study that looks at the window of opportunity for treatment of PsA at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
TMP SMX Prophylaxis in GPA
Dr. Jack Cush and Dr. Janet Pope discuss abstract 1584 presented at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
The FOREMOST Study: Apremilast in PsA
Dr. Peter Nash reports on abstract 1691 presented at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
The SMART Study: Split Dose Oral Methotrexate
Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego.
Watch video →
Real World Experience with PEXIVAS Low Steroid Taper
Dr. Mike Putman discusses abstract 0725 with Dr. Sophie Nagle at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Cancer and TNF inhibitors
Cancer risk minimisation is a high priority for people with rheumatic diseases, as it is for the general population. Tumor necrosis factor inhibitors (TNFi) have a long history of association with cancer risk discussions. An oral presentation by Suarez-Almazor et al provided more supportive data on using TNFi in this population.
Read more →
#ACRbest Abstracts – Day 2
Our reporters have been prolific in finding the hot abstracts, those that were most attended or those that are getting the most buzz on social media. Here are RheumNow's #ACRbest abstract reports from Monday, November 13, 2023 at #ACR23, covering The Great Debate, SGLPT2 inhibitors in SLE, the SMART Study of MTX, TMP/SMX Prophylaxis, RA-ILD & TNF Inhibitors, cancer research and more.
Read more →
Effects of Apremilast on Cardiometabolic Effects in PsA
Dr. Peter Nash discusses abstract 1414 at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
An Interview with Kevin Winthrop: Three Questions About COVID 19
Drs. Jack Cush and Kevin Winthrop discuss COVID 19 at 2023 ACR Convergence in San Diego, CA.
Watch video →
Biologics as First-line Therapy for PMR and GCA?
Dr. Eric Dein talks with Dr. Philip Seo, one of two panelists for the Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset? at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
David Liew drdavidliew
2 years ago
@maferradastrong is an inspiration.
She was driven to improve outcomes for relapsing polychondritis, the disease she lives with, & now she leads her field.
Truly the model of a patient-physician, always so much to learn from her.
#ACR23 Review Course @RheumNow @Polychondritis https://t.co/1HJSFqgWEK
Dr. Antoni Chan
2 years ago
Relapsing polychondritis RP is a systemic condition and not just inflammation in the ears 👂 Ferrara M #ACR23 @RheumNow https://t.co/BXvyWYMYa0
Dr. Antoni Chan
2 years ago
Outcome scores for TTP, using the PLASMIC score to decide on treatment for TTP, Ortel T, #ACR23 @RheumNow https://t.co/Gbn7ZqkH5Y
Dr. Antoni Chan
2 years ago
The role of caplacizumab in the treatment of TTP, Ortel T #ACR23 @RheumNow https://t.co/VAWOlNBRuh
Bella Mehta bella_mehta
2 years ago
Subchondral bone lesions in #OA on the weight bearing regions are the source of pain - David Walsh excellent talk summarizing pain mechanisms. #ACR23 @RheumNow
David Liew drdavidliew
2 years ago
Recombinant ADAMTS13 therapy just @US_FDA approved - will save these patients recurrent plasma infusions (every couple of weeks for months), a big win.
https://t.co/lKdWTMp2oc
#ACR23 Review Course @RheumNow https://t.co/2NMbJvseiA
Dr. Antoni Chan
2 years ago
Summary of recommendations for thrombotic microangiopathy (TMA), think of ADAMTS13, Ortel T, #ACR23 @RheumNow https://t.co/eSaocPSLUH
Dr. John Cush RheumNow
2 years ago
RheumNow’s expanded coverage of the #ACR23 Annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.
Robert B Chao, MD
2 years ago
Bummed to miss sunny San Diego but still excited to join #ACR23 @RheumNow
Time to get some learnin' on!
Informative review on the role of systemic treatments and the rheumatologists role in ocular inflammation. https://t.co/0nFDEZHfGW
Dr. Antoni Chan
2 years ago
Things for me to take back to the clinic in looking after JIA patients, Sadun R, #ACR23 @RheumNow https://t.co/YkiP4GZG19
TheDaoIndex KDAO2011
2 years ago
Did you know about Tubulointerstitial nephritis uveitis (TINU) syndrome? Usually younger pts; uveitis may not be concurrent with the TIN. Risks: NSAID/abx, infx, genetics. Nice systematic review of this entity (link below). #boardquestion @rheumnow #ACR23 https://t.co/HDqLDHyGM6
Dr. Antoni Chan
2 years ago
Systemic inflammatory conditions related to scleritis #ACR23 @RheumNow https://t.co/qc6szUnOUl
Dr. Antoni Chan
2 years ago
Conditions diagnosed by ophthalmologists that require systemic therapy #ACR23 @RheumNow https://t.co/tPkdoH3m9c
TheDaoIndex KDAO2011
2 years ago
Isolated uveitis without systemic symptoms: Sympathetic ophthalmia, Birdshot chorioretinopathy, serpiginous , pars planitis -Dr L Kopplin @rheumnow #ACR23 #ACRReview https://t.co/prBVuZSJV7
Mike Putman EBRheum
2 years ago
FAST trial, MMF vs MTX at the Review Course today
Overall a big win for MTX, powered for noninferiority (bc people loved MMF) but looks like MTX won the day w/10% difference in outcomes
Take home: MTX FTW per usual
@RheumNow #ACR23 #ReviewCourse https://t.co/lY1V6S7X3d
Poster Hall